United Therapeutics | 销售和管理费用





销售和管理费用 更改 日
Amarin USD 17.94M 17.86M 2025-09
Ardelyx USD 83.61M 378K 2025-09
Baxter International USD 761M 53M 2025-12
Bayer EUR 3.4B 140M 2025-09
BioCryst Pharmaceuticals USD 80.47M 15.39M 2024-12
Biogen USD 545.2M 38.6M 2025-09
BioMarin Pharmaceutical USD 322.21M 98.79M 2025-12
Emergent BioSolutions USD 182.8M 82.3M 2023-06
Esperion Therapeutics USD 39.98M 4.21M 2024-09
Gilead Sciences USD 1.78B 425M 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
Halozyme Therapeutics USD 64.64M 27.11M 2025-12
Insmed USD 212.48M 26.11M 2025-12
Ionis Pharmaceuticals USD 86.56M 4.04M 2025-09
J&J USD 6.75B 831M 2025-12
Lexicon Pharmaceuticals USD 39.19M 7.13M 2024-06
Moderna USD 308M 40M 2025-12
Omeros USD 11.32M 2.48M 2024-09
Pfizer USD 4.08B 894M 2025-12
PTC Therapeutics USD 87.2M 3.15M 2025-12
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sarepta Therapeutics USD 77.11M 7.22M 2025-09
Teva Pharmaceutical Industries USD 1.12B 147M 2025-12
United Therapeutics USD 152M 60.5M 2025-09
Vertex Pharmaceuticals USD 487M 41.9M 2025-12


United Therapeutics 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.